Sustained Virologic Response Following a Shortened Course of Direct-Acting Antiviral Therapy in an HIV/HCV Co-Infected Patient With Previous Treatment Experience: A Case Report
Journal of Pharmacy Practice · 2025
DOI: 10.1177/08971900251408942 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Pharmacy Practice, 2025. Verfasst von Natasha Bhutani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacotherapy, The Brooklyn Hospital Center, Brooklyn, NY, USA. Hauptthemen laut MEDLINE: Antiviral Agents, HIV Infections, Carbamates, Hepatitis C, Chronic. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
We describe a 47-year-old treatment-experienced African-American man co-infected with human immunodeficiency virus (HIV) and chronic hepatitis C virus (HCV) who took sofosbuvir-velpatasvir-voxilaprevir (SOF/VEL/VOX) for approximately 4 weeks and achieved sustained virologic response 12 weeks post-treatment (SVR12). Prior to initiating SOF/VEL/VOX, the patient completed 10 weeks of treatment with SOF/VEL. After 1 month of SOF/VEL/VOX, the patient was lost to follow-up for 3 months. This case report illustrates that SVR12 may be achieved in treatment-experienced patients living with HIV/HCV who complete a shortened duration of triple-direct acting antiviral therapy. Healthcare professionals should consider obtaining an HCV-RNA to assess if SVR12 was achieved prior to re-initiating treatment in patients lost to follow-up or who did not complete therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacotherapy, The Brooklyn Hospital Center, Brooklyn, NY, USA.
- Department of Pharmacy, Monmouth Medical Center, Southern Campus, RWJBarnabas Health, Lakewood, NJ, USA.
- Department of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, USA.
- Program for AIDS Treatment and Health (PATH) Center, The Brooklyn Hospital Center, Brooklyn, NY, USA.
ORCID-Profile: Natasha Bhutani, Yoona Lee, Maria A Longo
Zitieren
APA
Bhutani, N., Lee, Y., Longo, M. A., & Berkowitz, L. (2025). Sustained Virologic Response Following a Shortened Course of Direct-Acting Antiviral Therapy in an HIV/HCV Co-Infected Patient With Previous Treatment Experience: A Case Report. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900251408942
Vancouver
Bhutani N, Lee Y, Longo MA, Berkowitz L. Sustained Virologic Response Following a Shortened Course of Direct-Acting Antiviral Therapy in an HIV/HCV Co-Infected Patient With Previous Treatment Experience: A Case Report. Journal of Pharmacy Practice. 2025. doi:10.1177/08971900251408942
BibTeX
@article{Bhutani2025,
author = {Bhutani, Natasha and Lee, Yoona and Longo, Maria A and Berkowitz, Leonard},
title = {Sustained Virologic Response Following a Shortened Course of Direct-Acting Antiviral Therapy in an HIV/HCV Co-Infected Patient With Previous Treatment Experience: A Case Report},
journal = {Journal of Pharmacy Practice},
year = {2025},
doi = {10.1177/08971900251408942}
}
EUVIMED